Wall Street expects a year-over-year increase in earnings on higher revenues when InMode (INMD) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important ...

InMode Ltd. boasts superior fundamentals, yet trades at undervalued market multiples due to its unique risk profile. The company is a leader in the global aesthetics market with proprietary RF-based ...

Despite INMD being down -22% since I recommended to Buy the stock in March, InMode Ltd. remains a highly profitable & innovative leader in the aesthetic industry. Stronger than expected macroeconomic ...

Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative ...

YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

Image source: The Motley Fool. Gross margins decline — Yair Malca stated, "GAAP and non-GAAP gross margins in Q3 were 78%, down from 82% reported in Q3 2024," citing the anticipated impact of tariffs ...

YOKNEAM, Israel, March 24, 2026 /PRNewswire/ --InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and ...

Investors in InMode Ltd. INMD need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 21, 2025 $10.00 Put had some of the highest implied ...

As of October 30, 2025, the average one-year price target for InMode is $16.98/share. The forecasts range from a low of $14.14 to a high of $22.05. The average price target represents an increase of ...

InMode (NASDAQ:INMD) delivered quarterly financial metrics affected by a notable year-over-year contraction in both revenue and profit metrics, which management attributed in part to lower preorder ...